Trial intelligence / Profile preview

Risedronate for Painful Hip Prosthesis Loosening

NCT02744482Phase 3Terminated

Sponsor
CHU de Limoges
Start
May 2016
Primary completion
Mar 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of risedronate in aseptic loosening of prosthetic joint, sponsored by CHU de Limoges. Started May 2016; status: terminated.

02

Drugs

risedronate
03

Conditions

aseptic loosening of prosthetic joint

Beyond the preview

Go deeper on NCT02744482.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02744482.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call